Scale & Govern · Sware

Streamlining Validation to Save Over $130K Annually and Accelerate Compliance | Global Gene Therapy CDMO Case Study

Global Gene Therapy CDMO (unnamed)Scale & GovernSwareRes_Q

A global CDMO operating nine manufacturing facilities faced fragmented validation processes across locations and rising FTE hours spent on outdated workflows, made more urgent by a Microsoft Dynamics ERP implementation. It implemented Res_Q to standardize validation documentation, add unified dashboards for leadership visibility, and support acquisition-driven growth on a scalable platform. Results included a 53% reduction in effort per project, $130K in projected annual labor savings (2,070 hours annually, equivalent to 1 FTE), 20–40% faster test execution, approval cycles cut from weeks to days, and successful early FDA approvals for three critical SaaS systems.

Sware is a GxP validation platform whose entire commercial focus is life sciences — used specifically to validate AI/ML systems' explainable, traceable decisions for regulatory scrutiny.

This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.

Source

Published by Sware on its own site — read the original case study on sware.com ↗